Tradestie Institutional Equity Comparison Engine

VVOS vs PACB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PACB Overall Edge

PACB Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pacific Biosciences of California, Inc. (PACB) driven by superior Momentum & Technical, Options & Structure while VVOS counters with relative strength in Growth & Margin. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus PACB at N/M Forward P/E and -333.0% operating margin (+5.5% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against PACB sits in BREAKDOWN (97th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VVOS N/M vs PACB N/M Fwd P/E
Growth & Margin Winner VVOS
Op Margin -107.9% vs -333.0% ยท YoY +34.9% vs +5.5%
Momentum & Technical Winner PACB
1Y -97.7% vs -7.4% ยท 52W Pos 0% vs 24%
Options & Structure Winner PACB
BREAKDOWN (N/A IV) vs BREAKDOWN (97th %ile IV)
VVOS NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap $1.9M
1M Return -59.25%
1Y Return -97.71%
Forward P/E N/M
Unified AI Score
36.4 / 100 SELL
Tech 25.0 Fund 35.0 Flow 50.0 Mom 30.0
PACB NASDAQ
Pacific Biosciences of California, Inc.
Laboratory Analytical Instruments
$1.63
-7.39% 1D
Market Cap $549.5M
1M Return -20.87%
1Y Return -7.39%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 55.0 Flow 70.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VVOS -97.71% PACB -7.39% Spread: +90.32 pp (PACB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VVOS Revenue PACB Revenue VVOS Op. Margin PACB Op. Margin Margin Edge
FY2018 N/A $80M N/A -128.4% PACB
FY2019 $10M $90M -92.8% -110.6% VVOS
FY2020 $10M $80M -92.1% -132.3% VVOS
FY2021 $20M $130M -120.7% -161.2% VVOS
FY2022 $20M $130M -156.2% -239.4% VVOS
FY2023 $10M $200M -125.3% -166.8% VVOS
FY2024 $20M $150M -74.3% -308.0% VVOS
FY2025 $20M $160M -114.1% -346.2% VVOS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VVOS (2) vs PACB (6)
Institutional Metric VVOS PACB Criterion Row Winner
Market Capitalization Scale $1.9M $549.5M Larger Scale PACB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +34.9% +5.5% Higher Growth VVOS
Operating Margin (TTM) Profitability -107.9% -333.0% Higher Margin VVOS
Net Profit Margin Profitability -121.8% -81.3% Higher Margin PACB
Return on Equity (ROE) Capital Efficiency -8585.3% -929.3% Higher ROE PACB
52-Week Range Position Momentum 0% ($0โ€“$3) 24% ($1โ€“$3) Stronger Trend PACB
Beta / 30D Volatility Risk Regime 1.70ฮฒ ยท 111% Vol 2.25ฮฒ ยท 104% Vol Lower Realized Risk PACB
Unified Institutional Score Composite Signal 36.4 / 100 (SELL) 50.1 / 100 (HOLD) Higher Composite PACB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VVOS vs PACB Buy Guide
VVOS BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VVOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PACB BREAKDOWN
16d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 97th %ile
IV Regime Extreme (>80th %ile)
Live PACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VVOS nor PACB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.